Biotech stock mailbag: mid-year assessment, where we go from here
TheStreet's Adam Feuerstein answers reader questions about biotech stocks.
'Mad Money' Lightning Round: Be Careful With Fitbit
Cramer says Dow Chemical is undervalued and Nokia is never coming back.
Jim Cramer's 'Mad Money' Recap: Here's Why It's Time to Start Buying Stocks
When investors get complacent, they miss out on great opportunities to buy, Cramer says.
Twitter Stock Leaps As Elon Musk Adds More Equity To $44 Billion Takeover Bid, Closes Tesla Margin Loan
Elon Musk has closed out his margin loans, linked to Tesla shares, and pledged another $6.25 billion in equity to fund his $44 billion takeover of the social media website.
Nvidia Stock: Investors Are Buying the Dip. Where From Here?
Nvidia stock is being bought on the dip. Here's how traders should approach it now.
Macy's Stock Soars On Q1 Earning Beat, 2022 Profit Forecast Boost As Shoppers Defy Inflation Gloom
"While macroeconomic pressures on consumer spending increased during the quarter, our customers continued to shop," said CEO Jeff Gennette.
Broadcom Agrees to Buy VMware in $61 Billion Cash-and-Stock Cloud Software Deal
"Combining our assets and talented team with Broadcom's existing enterprise software portfolio creates a remarkable enterprise software player," said VMware CEO Raghu Raghuram.